Brain Dynamics and Temporal Summation of Pain Predicts Neuropathic Pain Relief from Ketamine Infusion

被引:80
|
作者
Bosma, Rachael L. [1 ]
Cheng, Joshua C. [1 ,3 ]
Rogachov, Anton [1 ,3 ]
Kim, Junseok A. [1 ,3 ]
Hemington, Kasey S. [1 ,3 ]
Osborne, Natalie R. [1 ,3 ]
Raghavan, Lakshmikumar Venkat [2 ,4 ]
Bhatia, Anuj [1 ,2 ,4 ,5 ]
Davis, Karen D. [1 ,3 ,6 ]
机构
[1] Univ Hlth Network, Toronto Western Hosp, Div Brain Imaging & Behav Syst Neurosci, Krembil Brain Inst,Krembil Res Inst, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Western Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada
[3] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[4] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[6] Univ Toronto, Dept Surg, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
RECEPTOR ANTAGONIST DEXTROMETHORPHAN; 2ND PAIN; FUNCTIONAL CONNECTIVITY; CENTRAL SENSITIZATION; FIBROMYALGIA PATIENTS; MECHANISMS; MAINTENANCE; VALIDATION; INVENTORY; NETWORKS;
D O I
10.1097/ALN.0000000000002417
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Ketamine is an N-methyl-d-aspartate receptor antagonist that reduces temporal summation of pain and modulates antinociception. Ketamine infusions can produce significant relief of neuropathic pain, but the treatment is resource intensive and can be associated with adverse effects. Thus, it is crucial to select patients who might benefit from this treatment. The authors tested the hypothesis that patients with enhanced temporal summation of pain and the capacity to modulate pain via the descending antinociceptive brain pathway are predisposed to obtain pain relief from ketamine. Methods: Patients with refractory neuropathic pain (n = 30) and healthy controls underwent quantitative sensory testing and resting-state functional magnetic resonance imaging and then completed validated questionnaires. Patients then received outpatient intravenous ketamine (0.5 to 2mg . kg(-1). h(-1); mean dose 1.1 mg .kg(-1) . h(-1)) for 6h/day for 5 consecutive days. Pain was assessed 1 month later. Treatment response was defined as greater than or equal to 30% pain relief (i.e., reduction in pain scores). We determined the relationship between our primary outcome measure of pain relief with pretreatment temporal summation of pain and with brain imaging measures of dynamic functional connectivity between the default mode network and the descending antinociceptive brain pathway. Results: Approximately 50% of patients achieved pain relief (mean SD; Responders, 61 +/- 35%; Nonresponders, 7 +/- 14%). Pretreatment temporal summation was associated with the effect of ketamine (rho = -0.52, P = 0.003) and was significantly higher in Responders (median [25th, 75th] = 200 [100, 345]) compared with Nonresponders (44 [9, 92]; P = 0.001). Pretreatment dynamic connectivity was also associated with the clinical effect of ketamine (rho = 0.51, P = 0.004) and was significantly higher in Responders (mean +/- SD, 0.55 +/- 0.05) compared with Nonresponders (0.51 +/- 0.03; P = 0.006). Finally, the dynamic engagement of the descending antinociceptive system significantly mediated the relationship between pretreatment pain facilitation and pain relief (95% CI, 0.005 to 0.065). Conclusions: These findings suggest that brain and behavioral measures have the potential to prognosticate and develop ketamine-based personalized pain therapy.
引用
收藏
页码:1015 / 1024
页数:10
相关论文
共 50 条
  • [41] Age effects on pain thresholds, temporal summation and spatial summation of heat and pressure pain
    Lautenbacher, S
    Kunz, M
    Strate, P
    Nielsen, J
    Arendt-Nielsen, L
    PAIN, 2005, 115 (03) : 410 - 418
  • [42] Temporal Summation in Chronic Pelvic Pain
    Thompson, Heather D.
    Tang, Selphee
    Jarrell, John F.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2020, 42 (05) : 556 - 560
  • [43] Dynamic Functional Brain Connectivity Underlying Temporal Summation of Pain in Fibromyalgia
    Cheng, Joshua C.
    Anzolin, Alessandra
    Berry, Michael
    Honari, Hamed
    Paschali, Myrella
    Lazaridou, Asimina
    Lee, Jeungchan
    Ellingsen, Dan-Mikael
    Loggia, Marco L.
    Grahl, Arvina
    Lindquist, Martin A.
    Edwards, Robert R.
    Napadow, Vitaly
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (04) : 700 - 710
  • [44] The Presence of Neuropathic Pain Predicts Postoperative Neuropathic Pain Following Trigeminal Nerve Repair
    Zuniga, John R.
    Yates, David M.
    Phillips, Ceib L.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 72 (12) : 2422 - 2427
  • [45] Food-Derived Natural Compounds for Pain Relief in Neuropathic Pain
    Lim, Eun Yeong
    Kim, Yun Tai
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [46] Postoperative pain relief with epidural infusion
    Lofving, K.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2007, 51 : 47 - 48
  • [47] Ketamine for procedural pain relief in newborn infants
    Saarenmaa, E
    Neuvonen, PJ
    Huttunen, P
    Fellman, V
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2001, 85 (01): : F53 - F56
  • [48] Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report
    Juliao, Miguel
    Ulrich, Joao
    Calaveiras, Patricia
    Costa, Elisabeth
    Lucas, Isabel
    de Sousa, Paulo Faria
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2023, 13 (E3) : e902 - e907
  • [49] Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop
    Shindou, Hideo
    Shiraishi, Seiji
    Tokuoka, Suzumi M.
    Takahashi, Yoshikazu
    Harayama, Takeshi
    Abe, Takaya
    Bando, Kana
    Miyano, Kanako
    Kita, Yoshihiro
    Uezono, Yasuhito
    Shimizu, Takao
    FASEB JOURNAL, 2017, 31 (07): : 2973 - 2980
  • [50] The glutamatergic system as a target for neuropathic pain relief
    Osikowicz, Maria
    Mika, Joanna
    Przewlocka, Barbara
    EXPERIMENTAL PHYSIOLOGY, 2013, 98 (02) : 372 - 384